Ascend Capital’s Elevance Health ELV Stock Holding History

Ascend Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$6.56M	Buy	+23,929	New	+$6.21M	0.33%	88
2017 Q2	–	Sell	-101,413	Closed	-$16.8M	–	165
2017 Q1	$16.8M	Buy	+101,413	New	+$16.1M	0.76%	50
2016 Q4	–	Sell	-78,792	Closed	-$9.87M	–	145
2016 Q3	$9.87M	Buy	78,792 +18,190	+30%	+$2.35M	0.6%	59
2016 Q2	$7.96M	Buy	+60,602	New	+$8.29M	0.52%	76

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ascend Capital's ELV Position: Q3 2018 in Review

Ascend Capital opened a new position in Elevance Health (ELV) in Q3 2018: 23,929 shares worth $6.56M. The stake represents 0.33% of the portfolio and ranks #88 among its holdings. This is a return to the name: Ascend Capital previously reported a position in ELV as recently as Q1 2017.

Ascend Capital first reported a position in ELV in Q2 2016 and has held it in 4 quarters since. The position peaked at $16.8M in Q1 2017. 945 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

Ascend Capital held 23,929 shares of Elevance Health worth $6.56M as of Q3 2018.
Elevance Health was a new Ascend Capital position in Q3 2018.
Elevance Health made up 0.33% of Ascend Capital's portfolio in Q3 2018, its #88 holding.
Ascend Capital first reported a position in Elevance Health in Q2 2016 and has held it in 4 quarters since.
Ascend Capital's Elevance Health position peaked at $16.8M in Q1 2017.
945 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.